Chrome 2001
.
The Trusted Source InteliHealth Aetna InteliHealth InteliHealth
Enter Drug Name . Enter Search Term
     
. .
. .
.
Home
InteliHealth Dental
Drug Resource Center
Ask the Expert
Interactive Tools

InteliHealth Policies
Site Map

.
Diseases & Conditions Healthy Lifestyle Your Health Look It Up
Health News Health News
.
Associated Press

Expert Panel To View Confidential Swine Flu Papers
May 19, 2010

GENEVA (AP) -- An expert panel investigating the World Health Organization's response to last year's swine flu outbreak said Wednesday it wants to see confidential exchanges between the U.N. body and drug companies.

The 29-member panel will seek WHO records and correspondence from before and after the H1N1 strain was declared a pandemic in June, said committee chairman Harvey Fineberg, who is also president of the Institute of Medicine in Washington.

"We will want to have access to certain confidential documents that may be in place here at WHO or elsewhere," Fineberg told reporters in Geneva.

The documents include "contractual or letters of understanding" between the pharmaceutical industry and WHO, he said. "Some of the agreements with industry that we would like to examine have been considered confidential," but so far all of the panel's requests have been met, he said.

WHO spokesman Gregory Hartl said he couldn't immediately comment.

Under criticism for how the outbreak was handled, WHO Director-General Margaret Chan convened the panel last month and urged its members to conduct a "credible and independent review" that she promised would be transparent.

The Geneva-based agency has denied allegations that it gave pharmaceutical companies privileged access to national decision-makers.

Governments around the world spent millions of dollars (euros) buying antiviral drugs and flu vaccines in anticipation of a serious outbreak that never happened.

Among the companies that benefited was Switzerland's Roche Group, which saw sales of its Tamiflu antiviral medication jump by 2 billion Swiss francs ($1.74 billion) last year. British firm GlaxoSmithKline PLC sold both vaccines and its antiviral Relenza, while France's Sanofi-Aventis SA and U.S.-based Baxter International made vaccines. Some companies donated medicine to poor countries.

WHO has confirmed 18,036 deaths from the H1N1 strain over the past year -- far fewer than would have died from seasonal flu during the same period.

Chan said this week at a meeting of WHO's 193 member states that the world had been "just plain lucky" that swine flu wasn't deadlier.

The panel's final report is expected to be finished next year, and will be made public, Fineberg said.

Copyright 2010 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

.
InteliHealth
. . . .
.
More News
InteliHealth .
.
General Health
Top News
This Week In Health
Addiction
Allergy
Alzheimer's
Asthma
Arthritis
Babies
Breast Cancer
Cancer
Caregiving
Cervical Cancer
Children's Health
Cholesterol
Complementary & Alternative Medicine
Dental / Oral Health
Depression
Diabetes
Ear, Nose And Throat
Environmental Health
Eyes
Family Health
Fitness
Genetics
Headache
Health Policy
HIV / AIDS
Heart Health
Lung Cancer
Medications
Infectious Diseases
Men's Health
Nutrition News
Mental Health
Multiple Sclerosis
Nutrition Guide
Parkinson's
Pregnancy
Prevention
Prostate Cancer
Senior Health
Sexual / Reproductive Health
Sleep
Tobacco Cessation
STDs
Stress Reduction
Stroke
Weight Management
Today In Health History
Women's Health
Workplace Health
.
.
.
.
InteliHealth

   
.
.  
This website is certified by Health On the Net Foundation. Click to verify.
.
Chrome 2001
Chrome 2001